Our experts will be onsite at BIO Europe Spring. Join them to explore commercialization models and options for your assets. Learn how EVERSANA provides smart launch strategies and commercialization models that build value for your asset. EVERSANA offers alternatives to selling, out-licensing or launching internally. Join us for a conversation.
The life sciences sector has been long overdue for transformation. Fueled by increasing pressures on both established and emerging pharmaceutical companies, combined with investment market volatility, regional and regulatory complexities, and the need to improve both brand value and patient impact, we reinvented commercialization.
EVERSANA provides the industry’s only option for fully integrated commercial services to solve any drug pricing, promotion, access, reimbursement, adherence, or product delivery challenge.
Transformed by data and digital innovation, EVERSANA activates our future-ready infrastructure and proven industry expertise to manage the complete launch and commercialization of your product portfolio or address specific program or patient needs.
Explore our commercial models:
- EVERSANA COMPLETE Commercialization– Gain full access to a ready-to-deploy, high-performance commercialization and distribution engine, reducing the need to build your own commercial infrastructure.
- EVERSANA REIGNITE – Designed for large pharma’s established brand portfolios, this service maximizes product value before loss of exclusivity and optimizes revenue during the late stages of the product life cycle.